| Application no. and date | 20176370.3 (espacenet) (Federated) (European Patent Register), 20090916 | | Patent/reg. no. and date | DK/EP 3747464, 20240626 | | Publication date | 20201209 | | Priority no. and date | US 97464 P, 20080916 | | EP pub. no. and date |
EP 3747464 20201209 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | P85002DK01 | | Inventor | Smith, Craig, 1507, 42nd Avenue East
Seattle, Washington 98112, US,
Chin, Peter S., 855 Folsom Street Unit 329
San Francisco, California 94107, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 25/00 (2006.01) , A61P 25/28 (2006.01) , C07K 16/28 (2006.01) | | Title | Fremgangsmåder til behandling af progressiv multipel sklerose under anvendelse af et anti-CD20-antistof | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
